Skip to main content
Equibles
CCCC logo

CCCC · C4 Therapeutics, Inc.

Track CCCC — free

Use CCCC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CCCC

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.00 -0.03 (-0.74%) At close · Aug 21
Market Cap
$495.79M
Shares
123.03M

C4 Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for C4 Therapeutics, Inc. (CCCC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲350.7% $12.01M −$17.72M '24 Q2 24-08-01 ▲38.7% $15.36M −$24.67M '24 Q3 24-10-31 ▲58.8% $5.18M −$34.57M '24 Q4 25-01-14 ▼46.2% $6.46M −$26.02M '25 Q2 25-08-07 LATEST ▼15% $6.15M −$25.13M '26 Q1 26-05-26
Conference
Investor event
2026-09-10
2026 Wells Fargo Healthcare Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-26
C4 Therapeutics, Inc. Q1 FY2026 Earnings Call
Revenue
$6.15M
▼ 15% YoY
Diluted EPS
$-0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
C4 Therapeutics, Inc. Q2 FY2025 Earnings Call
Revenue
$6.46M
▼ 46.2% YoY
Diluted EPS
$-0.37
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-14
C4 Therapeutics, Inc. Q4 FY2024 Earnings Call
Revenue
$5.18M*
▲ 58.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
C4 Therapeutics, Inc. Q3 FY2024 Earnings Call
Revenue
$15.36M
▲ 38.7% YoY
Diluted EPS
$-0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
C4 Therapeutics, Inc. Q2 FY2024 Earnings Call
Revenue
$12.01M
▲ 350.7% YoY
Diluted EPS
$-0.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–7 of 7 earnings calls
Key facts CIK 1662579 CUSIP 12529R107 13F (30d) 144 filings 139 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)